Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

about

The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma.

P2860

Q47150674-C1E22109-CE3D-4A47-8721-56F9851423DE

P2860

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

Item

http://www.wikidata.org/entity/Q52899766

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

@en

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

@nl

type

Item

label

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

@en

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

@nl

prefLabel

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

@en

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

@nl

P1476

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

@en

P2093

Daniel Pfalzgraf

http://www.w3.org/2001/XMLSchema#string

Julia Dürr

http://www.w3.org/2001/XMLSchema#string

Maurice Stephan Michel

http://www.w3.org/2001/XMLSchema#string

Maximilian Christian Kriegmair

http://www.w3.org/2001/XMLSchema#string

Nina Huck

http://www.w3.org/2001/XMLSchema#string

Nina Wagener

http://www.w3.org/2001/XMLSchema#string

Philipp Mandel

http://www.w3.org/2001/XMLSchema#string

Philipp Nuhn

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolism of kidney cancer: from the lab to clinical practice

Novel drugs that target the metabolic reprogramming in renal cell cancer

Metabolic syndrome and renal cell carcinoma

Comprehensive molecular characterization of clear cell renal cell carcinoma.

Cancer statistics, 2016

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.

The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies

Insulin-like growth factor-1 signaling in renal cell carcinoma

The role of obesity in cancer survival and recurrence.

P2888

s12672-017-0289-2

P304

127-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12672-017-0289-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Porubsky

P577

2017-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28247362

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

about

P2860

P2860

Metabolic Syndrome Negatively Impacts the Outcome of Localized Renal Cell Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921